Washington Growth Strategies’s Gilead Sciences GILD Stock Holding History

Washington Growth Strategies’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$387K	Buy	+3,062	New	+$403K	0.21%	52

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Washington Growth Strategies's GILD Position: Q2 2026 in Review

Washington Growth Strategies opened a new position in Gilead Sciences (GILD) in Q2 2026: 3,062 shares worth $387K. The stake represents 0.21% of the portfolio and ranks #52 among its holdings.

1,019 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Washington Growth Strategies held 3,062 shares of Gilead Sciences worth $387K as of Q2 2026.
Gilead Sciences was a new Washington Growth Strategies position in Q2 2026.
Gilead Sciences made up 0.21% of Washington Growth Strategies's portfolio in Q2 2026, its #52 holding.
1,019 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Washington Growth Strategies's 13F filing for Q2 2026, filed 16 Jul 2026.